BINDING OF CARPROFEN TO HUMAN AND BOVINE SERUM ALBUMINS

Citation
H. Kohita et al., BINDING OF CARPROFEN TO HUMAN AND BOVINE SERUM ALBUMINS, Chemical and Pharmaceutical Bulletin, 42(4), 1994, pp. 937-940
Citations number
20
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
ISSN journal
00092363
Volume
42
Issue
4
Year of publication
1994
Pages
937 - 940
Database
ISI
SICI code
0009-2363(1994)42:4<937:BOCTHA>2.0.ZU;2-K
Abstract
The binding of carprofen (CP) to human serum albumin (HSA) and bovine serum albumin (BSA) was compared using equilibrium dialysis method. Th e affinity of CP for the primary binding site was BSA>HSA. However, th e number of primary binding sites (n(1)) was 1.94 on HSA, considerably greater than that on BSA (0.79). The displacement of the binding of C P to HSA and BSA was studied in the presence of phenylbutazone (PB, si te I marker), ibuprofen OB, site II marker) or 2,3,5-triiodobenzoic ac id (TIB, both site I and II marker). The binding of CP to HSA was alte red by PB, IB and TIB, while the binding of CP to BSA was not changed by PB, although it was reduced by IB and TIB. These results suggested that, for the binding of CP, HSA has two major sites (site I and site n), whereas BSA has a single primary site (site II). The binding chara cteristics of 2-anthracenecarboxylic acid with HSA and BSA were found quite similar to those of CP. Thus, it seemed that long, planar compou nds with a carboxyl group at one end can bind to site I and site II on HSA, but only to site II on BSA. The difference between HSA and BSA i n the affinity of site I may be due to the difference in the basic and hydrophobic amino acid residues.